Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes.

Saved in:
Bibliographic Details
Title: Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes.
Authors: Lu, Chang1,2 (AUTHOR), Wei, Xue-Wu2 (AUTHOR), Zhang, Yi-Chen2 (AUTHOR), Chen, Zhi-Hong2 (AUTHOR), Xu, Chong-Rui2 (AUTHOR), Zheng, Ming-Ying2 (AUTHOR), Yang, Jin-Ji2 (AUTHOR), Zhang, Xu-Chao2 (AUTHOR), Zhou, Qing1,2 (AUTHOR) gzzhouqing@126.com
Source: Journal of Cancer Research & Clinical Oncology. Jul2023, Vol. 149 Issue 7, p2987-2995. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01715216
DOI:10.1007/s00432-022-04188-7